Skip to content
Medical Health Aged Care

InMode Australia issues warning on counterfeit Morpheus8 devices threatening patient safety.

InMode Australia 2 mins read

InMode Australia, the company behind the award-winning Morpheus8 technology, is warning Australian clinics and patients about the growing risk of counterfeit radiofrequency (RF) microneedling devices being marketed as “Morpheus8.”

Morpheus8, trusted by practitioners worldwide and supported by clinical research, has become a recognised leading technology for skin revitalisation and contouring. However, its success has led to imitation devices that put patient safety and clinic reputations at risk.

 

Counterfeit Devices Pose Serious Safety Concerns

While counterfeit devices may appear visually similar to Morpheus8, they are unregulated, untested, and not listed on the Australian Register of Therapeutic Goods (ARTG). These devices often come from sub-standard facilities and lack the engineered safety features and sterile, single-use microneedling cartridges embedded with RFID chips that define genuine InMode technology.

“The risks are significant,” said Dennis Cronje, Managing Director of InMode Australia. “Counterfeit devices not only compromise treatment outcomes but also expose patients to risks such as burns, scarring, and infection. Clinics using these devices are also operating without insurance coverage and outside regulatory compliance.”

 

Why Authenticity Matters

Only InMode-supplied Morpheus8 devices are ARTG-listed and supported by global clinical trials. Treatments performed by certified InMode providers ensure:

  • Medically engineered devices with patented RF microneedling technology
  • Trained, verified practitioners using sterile, single-use cartridges
  • Consistent, predictable outcomes when performed by trained providers.

“Morpheus8 has earned its global reputation because it delivers results patients can trust, in the hands of providers who are comprehensively trained and supported,” Cronje added. “There is no substitute for authenticity when it comes to medical aesthetics.”

 

InMode’s Action Against Counterfeits

InMode has taken international legal action to combat counterfeit devices, resulting in shutdowns of illegal sellers and the removal of non-approved devices from the market (https://www.prnewswire.com/news-releases/inmode-granted-injunction-against-counterfeit-sales-of-morpheus8-radio-frequency-microneedling-devices-and-needle-cartridges-302446235.html). Locally, InMode Australia continues to monitor for counterfeit activity and urges both clinics and patients to report suspected fakes.

How to Spot a Genuine Morpheus8

Patients/clients are encouraged to protect themselves by looking for a clinic that:

  • Displays the official InMode Verified Provider badge
  • Uses devices with the InMode logo and approved RFID-embedded cartridges
  • Is listed on InMode Australia’s verified provider directory

To learn more, visit https://www.inmode.com.au/blogs/news/the-truth-about-counterfeit-morpheus8-devices-and-how-to-protect-your-skin or email [email protected]


About us:

About InMode Australia

InMode is a leading global provider of innovative aesthetic technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology, light-based applications including IPL and laser, and EMS. InMode strives to enable new emerging non-surgical procedures as well as improving and complimenting existing treatments. InMode has leveraged its medically accepted minimally invasive RF technologies to offer a comprehensive line of products across several categories including plastic and cosmetic surgery, dermatology, optometry and ophthalmology, gynaecology, women’s health, and cosmetic clinics.


Contact details:

Marton Jakab Head of Marketing - InMode Australia

Phone: (02) 7209 5678 Mobile: 0477 884 773

Email: [email protected]

Website: www.inmode.com.au

Media

More from this category

  • Medical Health Aged Care
  • 19/03/2026
  • 06:57
Royal Australian College of GPs

Strong rural growth sees 530 more GPs training in NSW, but state still ‘playing catchup’ in too many regions: RACGP

Rural NSW patients will have easier access to general practice care following strong growth in the number of GPs training in the Commonwealth-funded Australian GP Training (AGPT) Program with the Royal Australian College of GPs (RACGP). However, Australia’s leadingmedical training college has warned more investment is still needed to improve rural health equity. In 2026, 530 future GPs have commenced training in NSW, 27% more than in 2025. Of these: 255 on an AGPT rural training pathway will spend all three years of their training in regional, rural, or remote areas, an 88.8% increase on 2025 203 on a general…

  • Contains:
  • Medical Health Aged Care
  • 19/03/2026
  • 06:25
Royal Australian College of GPs

Targeted investment would strengthen general practice and relieve pressure on ACT hospitals: RACGP

Pressure on overstretched emergency departments and hospital services will continue to worsen unless the ACT Government delivers targeted, high-impact general practice investment in the 2026-27 ACT Budget, The Royal Australian College of GPs (RACGP) has said. Releasing its 2026-27 ACT Prebudget Submission, RACGP ACT Chair, Dr Rebekah Hoffman, said the Territory’s small geographic size allows for strategic, focused investment that can deliver outsized benefits across the entire health system. “The ACT’s health system is under real strain, from chronic disease, population growth, hospital demand and workforce shortages,” she said. “General practice is the most efficient and effective part of the…

  • Contains:
  • Government Federal, Medical Health Aged Care
  • 19/03/2026
  • 06:00
Doctors for the Environment Australia

Open Letter: Healthcare professionals warn oil dependence is harming Australians’ health amid global instability

GPs, specialists and other healthcare professionals are signing an open letter calling for the Albanese Government to accelerate the shift to clean energy. They warn that dependence on global oil is driving up living costs and harming public health—particularly as conflict in the Middle East disrupts fuel markets. Dr Kate Wylie, a GP and the executive director of Doctors for the Environment Australia (DEA), which organised the open letter: “Our dependence on global oil is exposing Australians—especially those in outer suburbs and rural areas—to rising costs for fuel, groceries and mortgage repayments, as well as physical and mental health harms.…

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.